1. Late Fate of Cryopreserved Arterial Allografts
- Author
-
Ch. Holemans, E. Minga Lowampa, L. Stiennon, H. Van Damme, and Jean Defraigne
- Subjects
medicine.medical_specialty ,Prosthesis-Related Infections ,Time Factors ,Fistula ,Aortic Diseases ,Economic shortage ,030204 cardiovascular system & hematology ,030230 surgery ,Anastomosis ,Cryopreservation ,Blood Vessel Prosthesis Implantation ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Risk Factors ,Intestinal Fistula ,medicine ,Retrospective analysis ,Humans ,Hospital Mortality ,Registries ,Device Removal ,Retrospective Studies ,Prosthetic infection ,Vascular Fistula ,business.industry ,Graft Survival ,Arteries ,Allografts ,medicine.disease ,Thrombosis ,Anti-Bacterial Agents ,Blood Vessel Prosthesis ,Surgery ,Treatment Outcome ,Arterial infection ,Cardiology and Cardiovascular Medicine ,business - Abstract
Objective Initial enthusiasm for use of cryopreserved arterial allografts was subsequently tempered by suboptimal long-term outcome. Thrombosis, anastomotic pseudo-aneurysm, allograft disruption, aneurysmal degeneration, recurrent intestinal fistulization, and persistent infection are commonly reported in series with long-term follow-up. The authors reviewed their experience over the past 15 years with the use of cryopreserved arterial allografts as a vascular substitute for vascular prosthetic infection or for primary arterial infection, to investigate allograft-related complications. Material and methods A retrospective analysis of prospectively collected data was conducted for 103 cryopreserved arterial allografts inserted in 96 patients between July 2000 and July 2015. There were 78 patients with infected vascular prosthesis (IVP), nine patients with an aorto-enteric fistula (AEF), and nine patients with primary arterial infection (PAI). Results The in-hospital mortality was eight out of 78 (9%) IVP patients, three out of nine AEF patients, and zero out of nine PAI patients. Median follow-up was 49 months. Allograft-related re-interventions were necessary in 29% of the patients with IVP and four of the patients with AEF, but none of the patients with PAI. Five-year survival for the IVP, AEF, and PAI patients was 53%, 44%, and 90%, respectively. Conclusion This series highlights some shortcomings of cryopreserved arterial allografts in the long term, including suboptimal outcome-results and shortage of material. The authors discuss the allograft-related complications and suggest some tricks to minimize their risk.
- Published
- 2016
- Full Text
- View/download PDF